Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Cancer Causes & Control
Published in: Cancer Causes & Control 6/2002

01-08-2002

Serum selenium and the risk of cervical cancer among women in the United States

Authors: Frances E. Thompson, Blossom H. Patterson, Stephanie J. Weinstein, Mary McAdams, Vickie L. Spate, Richard F. Hamman, Robert S. Levine, Katherine Mallin, Paul D. Stolley, Louise A. Brinton, J. Steven Morris, Regina G. Ziegler

Published in: Cancer Causes & Control | Issue 6/2002

Login to get access
Metadata
Title
Serum selenium and the risk of cervical cancer among women in the United States
Authors
Frances E. Thompson
Blossom H. Patterson
Stephanie J. Weinstein
Mary McAdams
Vickie L. Spate
Richard F. Hamman
Robert S. Levine
Katherine Mallin
Paul D. Stolley
Louise A. Brinton
J. Steven Morris
Regina G. Ziegler
Publication date
01-08-2002
Publisher
Kluwer Academic Publishers
Published in
Cancer Causes & Control / Issue 6/2002
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1023/A:1016328407610

Other articles of this Issue 6/2002

Cancer Causes & Control 6/2002 Go to the issue

OriginalPaper

Report from a symposium on diet and breast cancer

Editorial Commentary

In-utero exposures and breast cancer risk: joint effect of estrogens and insulin-like growth factor?

OriginalPaper

Nonlinear relationship of insulin-like growth factor (IGF)-I and IGF-I/IGF-binding protein-3 ratio with indices of adiposity and plasma insulin concentrations (Sweden)

OriginalPaper

A prospective cohort study on intake of retinol, vitamins C and E, and carotenoids and prostate cancer risk (Netherlands)

OriginalPaper

Folate, methionine, alcohol, and colorectal cancer in a prospective study of women in the United States

OriginalPaper

Aspirin, other NSAIDs, and ovarian cancer risk (United States)
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits